Exploring vaccinia virus as a tool for large-scale recombinant protein expression.

Printer-friendly versionPrinter-friendly versionPDF versionPDF version
TitleExploring vaccinia virus as a tool for large-scale recombinant protein expression.
Publication TypeJournal Article
Year of Publication2003
AuthorsBleckwenn, NA, Bentley, WE, Shiloach, J
JournalBiotechnol Prog
Volume19
Issue1
Pagination130-6
Date Published2003 Jan-Feb
ISSN8756-7938
KeywordsBioreactors, Feasibility Studies, Gene Expression Regulation, Viral, Gene Transfer Techniques, Green Fluorescent Proteins, HeLa Cells, Humans, Luminescent Proteins, Pilot Projects, Protein Engineering, Quality Control, Recombinant Proteins, Vaccinia virus
Abstract

A recombinant vaccinia virus was engineered to express enhanced green fluorescent protein (EGFP) under control of the T7 promoter using the VOTE expression system in HeLa cells. Infection of HeLa cells with this virus and induction with IPTG demonstrated the utility of this construct for easily measuring protein expression. This construct was used to evaluate several production parameters, specifically, multiplicity of infection (MOI), volume during infection, and serum concentration during the infection phase. In static culture, increasing multiplicity of infection was found to increase expression of EGFP up to a plateau around MOI of 1.0. Expression was also shown to increase with decreasing volume during the infection phase. Serum concentration during the infection phase was only marginally significant from 0 to 7.5%. Cytodex 3 microcarriers were found to have the best characteristics for HeLa cell growth. These cells were grown and infected in microcarrier spinner flask culture, and the maximum expression was 2.2 microg EGFP/(million cells at the time of infection), demonstrating the ability of this system to successfully express recombinant proteins at larger scale.

DOI10.1021/bp0255762
Alternate JournalBiotechnol. Prog.
PubMed ID12573015